Organovo Holdings Inc
NASDAQ:ONVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Organovo Holdings Inc
NASDAQ:ONVO
|
US |
|
Z
|
Zapf Creation AG
XMUN:ZPF
|
DE |
|
Sumitomo Forestry Co Ltd
TSE:1911
|
JP |
|
Lionsgate Studios Corp
NASDAQ:LION
|
US |
|
A
|
Aclara Resources Inc
TSX:ARA
|
CL |
|
A
|
Alpargatas SA
BOVESPA:ALPA3
|
BR |
|
C
|
Companhia Paranaense de Energia
BOVESPA:CPLE6
|
BR |
|
T
|
T.S. Lines Ltd
HKEX:2510
|
TW |
|
YTL Corporation Bhd
KLSE:YTL
|
MY |
|
Absci Corp
NASDAQ:ABSI
|
US |
|
Olaplex Holdings Inc
NASDAQ:OLPX
|
US |
|
Shoe Carnival Inc
NASDAQ:SCVL
|
US |
|
F
|
Fast Accounting Co Ltd
TSE:5588
|
JP |
|
Wakachiku Construction Co Ltd
TSE:1888
|
JP |
|
N
|
Netum Group Oyj
OMXH:NETUM
|
FI |
|
Natuzzi SpA
NYSE:NTZ
|
IT |
|
H
|
Headway Advanced Materials Inc
TWSE:1776
|
TW |
|
Kemira Oyj
F:KEM
|
FI |
|
S
|
Sprout AI Inc
CNSX:BYFM
|
CA |
|
Garnet International Ltd
BSE:512493
|
IN |
|
F
|
Fineqia International Inc
CNSX:FNQ
|
CA |
|
J
|
Jwipc Technology Co Ltd
SZSE:001339
|
CN |
|
Strong H Machinery Technology (Cayman) Inc
TWSE:4560
|
KY |
|
AlzChem Group AG
XETRA:ACT
|
DE |
Relative Value
The Relative Value of one
ONVO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.87 USD,
Organovo Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ONVO Competitors Multiples
Organovo Holdings Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Organovo Holdings Inc
NASDAQ:ONVO
|
3.2m USD | 26.1 | -0.3 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |